Medicenna Therapeutics Corp. Common Shares
MDNA
MDNA was delisted on the 1st of November, 2023.
25 hedge funds and large institutions have $8.66M invested in Medicenna Therapeutics Corp. Common Shares in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 8 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
4% less funds holding
Funds holding: 26 → 25 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
42% less capital invested
Capital invested by funds: $15.1M → $8.66M (-$6.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LBA
Letko, Brosseau & Associates
Montreal,
Quebec, Canada
|
+$248K |
| 2 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$156K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$80K |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$75.6K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$42.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$3.02M |
| 2 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$2.9M |
| 3 |
MS
Maven Securities
St Helier,
Jersey
|
-$234K |
| 4 |
JP Morgan Chase
New York
|
-$77K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$73K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIC
26
AWM Investment Company
New York
| – | -$3.02M | -1,000,000 | Closed |
|
|
BOTOTLSJU
27
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
| – | -$2.9M | -962,932 | Closed |
|
|
SCM
28
Silverarc Capital Management
Boston,
Massachusetts
| – | -$333 | -110,515 | Closed |
|
|
MS
29
Maven Securities
St Helier,
Jersey
| – | -$234K | -79,118 | Closed |
|
|
30
JP Morgan Chase
New York
| – | -$77K | -25,500 | Closed |
|
|
31
Citadel Advisors
Miami,
Florida
| – | -$73K | -24,203 | Closed |
|
|
FDCDDQ
32
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$2.98K | -1,000 | Closed |
|
MDNA Hedge Fund Activity: Q3 2021 in Review
25 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Medicenna Therapeutics Corp. Common Shares (MDNA) for Q3 2021, worth a combined $8.66M — down 42% from $15.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of MDNA and 7 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 5 added.
The largest buyer was Letko, Brosseau & Associates, opening a new position worth an estimated $248K. The largest seller was AWM Investment Company, exiting entirely with an estimated $3.02M sold.
- 25 institutional investors held Medicenna Therapeutics Corp. Common Shares (MDNA) as of Q3 2021, down from 26 in Q2 2021.
- Funds reported $8.66M of Medicenna Therapeutics Corp. Common Shares stock for Q3 2021, down 42% quarter-over-quarter.
- 7 funds opened new Medicenna Therapeutics Corp. Common Shares positions in Q3 2021 and 8 closed out, a net change of -1 holder.
- The largest Medicenna Therapeutics Corp. Common Shares buyer in Q3 2021 was Letko, Brosseau & Associates, an estimated $248K added.
- The largest Medicenna Therapeutics Corp. Common Shares seller in Q3 2021 was AWM Investment Company, an estimated $3.02M sold.
Based on aggregated 13F filings for Q3 2021.